Clinical Trials Directory

Trials / Completed

CompletedNCT05529706

Community-based Brain Health Program to Address Dementia Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Posit Science Corporation · Industry
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This is a validation study to evaluate the acceptability, feasibility and preliminary efficacy of the Brain Health Program, a multimodal curriculum covering dementia risk factors and evidence-based change interventions. The goal of this study is to evaluate the Brain Health Program in individuals with identified risk factors for the onset of dementia and to prepare for a large-scale efficacy trial in this population.

Detailed description

This study will employ an evidence-based Brain Health Program curriculum, which involves a twelve-week, group-administered, personalized program designed to improve brain health in individuals with identified risk factors for the onset of dementia. This is a single-arm open-label feasibility study, enrolling older adults with Alzheimer's disease risk factors in a public health, community-deployed, group-based and individualized multimodal Brain Health Program (targeting, among other domains, diet, exercise and cognitive exercise), with a set of baseline assessments intended to characterize the population, and outcome measure to evaluate the usability of the program, as well as preliminary efficacy to reduce dementia risk factors.

Conditions

Interventions

TypeNameDescription
OTHERBrain Health ProgramThe Brain Health Program employs 1-hour/week group-based training and education regarding modifiable Alzheimer's disease dementia risk factors delivered over a 12-week period. Participants will be assigned into a group of up to 20 participants, and participants will engage the Brain Health Program collaboratively, as administered by the program content leader (instructor), while also being monitored and supported by the tech leader (in accordance with the Diabetes Prevention Program model).

Timeline

Start date
2023-04-24
Primary completion
2024-10-18
Completion
2024-10-18
First posted
2022-09-07
Last updated
2024-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05529706. Inclusion in this directory is not an endorsement.